Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

A new study by scientists has uncovered four groups of health problems that can eventually lead to Alzheimer's disease. It is ...

The earliest warning signs of Alzheimer's disease include memory loss that impacts your daily functioning, vision and ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Eating heavy meals at night can disrupt sleep quality and cognitive faculties..evening routine, brain health, Alzheimer's, ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label ...

Frontotemporal dementia or frontotemporal degeneration (FTD) refers to a range of disorders that impact the brain’s frontal ...

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...